Subtype
Endometrial Neoplasm
CI-CAN-00007648Explore in graph →
Non-malignant400 active trials4 approved drugs28 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00007648Explore in graph →
Clinical trials
1,340 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04651738 | Cell-free DNA Methylation for Endometrial Cancer | unknown | N/A | 400 | Lei LiOTHER | 1 | Dec 21, 2020 | clinicaltrials |
| NCT03877627 | The Clinical Significance of Sentinel Lymph Node Imaging Combined With Imaging Examination in Pelvic and Peritoneal Lymphadenectomy for Endometrial Carcinoma | unknown | N/A | 60 | Second Affiliated Hospital of Wenzhou Medical UniversityOTHER | 0 | Oct 29, 2020 | clinicaltrials |
| NCT04528940 | Tumor Grade Determines PD-1/PDL-1 Expression | unknown | — | 100 | RWJ Barnabas Health at Jersey City Medical CenterOTHER | 1 | Aug 27, 2020 | clinicaltrials |
| NCT04516083 | Lynch Syndrome Can be Diagnosed Just From Somatic Mismatch Repair Mutation | unknown | — | 100 | RWJ Barnabas Health at Jersey City Medical CenterOTHER | 1 | Aug 18, 2020 | clinicaltrials |
| NCT04514289 | To Assess and Compare the Performance Two Approach for Sentinel Lymph Node (SNLD) Biopsy for Endometrial Cancer | unknown | — | 106 | Haseki Training and Research HospitalOTHER | 1 | Aug 14, 2020 | clinicaltrials |
| NCT04489706 | Arsenic Trioxide in Recurrent and Metastatic Ovarian Cancer and Endometrial Cancer With P53 Mutation | unknown | N/A | 20 | Ruijin HospitalOTHER | 1 | Jul 28, 2020 | clinicaltrials |
| NCT04444193 | Durvalumab and Lenvatinib in Participants With Advanced and Recurrent Endometrial Carcinoma(Dulect2020-2) | unknown | N/A | 20 | Shanghai First Maternity and Infant HospitalOTHER | 0 | Jun 23, 2020 | clinicaltrials |
| NCT04073680 | A Phase 1b/2 Study of Serabelisib in Combination With Canagliflozin in Patients With Advanced Solid Tumors | unknown | Phase 1 / Phase 2 | 60 | Petra PharmaINDUSTRY | 0 | May 21, 2020 | clinicaltrials |
| NCT04295109 | Comparison of the Effects of Fentanyl, Oxycodone, Butorphanol on Gastrointestinal Function | unknown | N/A | 105 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | Apr 24, 2020 | clinicaltrials |
| NCT03349463 | Evaluation of Fluciclovine Uptake in Patients With Cervical, Ovarian Epithelial or Endometrial Cancers. | unknown | Phase 4 | 30 | Bital Savir-BaruchOTHER | 1 | Feb 28, 2020 | clinicaltrials |
| NCT03611517 | Sexual Rehabilitation Programme After Radiotherapy for Gynaecological Cancer(SPARC) | unknown | N/A | 220 | Leiden University Medical CenterOTHER | 1 | Feb 24, 2020 | clinicaltrials |
| NCT04235179 | Adjuvant Stereotactic Pelvic Irradiation in Endometrial Cancer(ASPIRE) | unknown | Phase 2 | 30 | King Saud UniversityOTHER | 1 | Jan 22, 2020 | clinicaltrials |
| NCT04224467 | The Application of Real-Time Near-infrared Imaging in Gynecological Surgery | unknown | N/A | 500 | Chen ChunlinOTHER | 1 | Jan 14, 2020 | clinicaltrials |
| NCT00800644 | Pelvic Fractures and Radiation Therapy for Cervical Cancer | unknown | — | 239 | M.D. Anderson Cancer CenterOTHER | 1 | Jan 13, 2020 | clinicaltrials |
| NCT03896113 | Neoadjuvant Celecoxib in Newly Diagnosed Patients With Endometrial Carcinoma(CELEBRIDO) | unknown | Phase 2 | 48 | Cliniques universitaires Saint-Luc- Université Catholique de LouvainOTHER | 1 | Jan 10, 2020 | clinicaltrials |
| NCT01447199 | The Molecular Predisposition to Hereditary Nonpolyposis Colon Cancer (HNPCC) | unknown | — | 2,000 | M.D. Anderson Cancer CenterOTHER | 1 | Jan 7, 2020 | clinicaltrials |
| NCT02545348 | Use of the Sentinel Node Biopsy for Early Endometrial Cancer.(SNE) | unknown | — | 100 | Cliniques universitaires Saint-Luc- Université Catholique de LouvainOTHER | 1 | Dec 16, 2019 | clinicaltrials |
| NCT04157491 | Anti-PD-1 Antibody Combined With Anlotinib in the Treatment of Endometrial Cancer | unknown | Phase 1 / Phase 2 | 23 | Sun Yat-sen UniversityOTHER | 1 | Nov 8, 2019 | clinicaltrials |
| NCT03595722 | Exploring HIFU as a Treatment for Rectal and Other Pelvic Cancers | unknown | N/A | 60 | Imperial College LondonOTHER | 1 | Aug 15, 2019 | clinicaltrials |
| NCT04046185 | Programmed Death-1(PD-1) Inhibitor Combined With Progesterone Treatment in Endometrial Cancer(ECCT) | unknown | Early Phase 1 | 60 | Shanghai First Maternity and Infant HospitalOTHER | 0 | Aug 6, 2019 | clinicaltrials |
| NCT01267851 | Clinical Database and Biobank of Patients With Gynecologic Neoplasms | unknown | — | 1,600,000 | Huazhong University of Science and TechnologyOTHER | 1 | Jul 19, 2019 | clinicaltrials |
| NCT04010487 | Multi-omics Study on the Pathogenesis of Malignant Transformation of Adenomyosis | unknown | — | 40 | Lei LiOTHER | 1 | Jul 18, 2019 | clinicaltrials |
| NCT03489473 | FESPET Study: Female EStrogen recePtor in Endometrial Cancer Treatment(FESPET) | unknown | — | 40 | Radboud University Medical CenterOTHER | 0 | Apr 18, 2019 | clinicaltrials |
| NCT00807768 | Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer | unknown | Phase 3 | 601 | Gynecologic Oncology GroupNETWORK | 2 | Mar 20, 2019 | clinicaltrials |
| NCT01295502 | Cisplatin and Radiation Therapy Followed by Paclitaxel and Carboplatin in Treating Patients With Stage IB-IVA Cervical Cancer | unknown | Phase 1 | 45 | Gynecologic Oncology GroupNETWORK | 1 | Mar 12, 2019 | clinicaltrials |
| NCT03112733 | Serum Biomarkers in Diagnosis and Predicting Prognosis of Ovarian Cancers | unknown | — | 171 | Ilker KahramanogluOTHER | 1 | Feb 26, 2019 | clinicaltrials |
| NCT03838055 | Sentinel Node Detection in Endometrial Cancer: A Consolidation Study on Detection Rates of Metastatic Disease | unknown | N/A | 362 | Region SkaneOTHER | 1 | Feb 12, 2019 | clinicaltrials |
| NCT02433626 | Study of COTI-2 as Monotherapy or Combination Therapy for the Treatment of Malignancies(COTI2-101) | unknown | Phase 1 | 51 | Critical Outcome Technologies Inc.INDUSTRY | 1 | Feb 1, 2019 | clinicaltrials |
| NCT03459976 | HE4 is a Beneficial Biomarker in Endometrial Cancer(HE4) | unknown | — | 87 | Ain Shams UniversityOTHER | 1 | Jan 25, 2019 | clinicaltrials |
| NCT03322176 | Healthcare Decisions Post-Testing, Risk-reducing and Preventative Strategies Using LYNCH Genetic Testing Reducing, and Preventative Strategies Using LYNCH Genetic Testing | unknown | — | 200 | Data Collection Analysis Business ManagementOTHER | 1 | Jan 23, 2019 | clinicaltrials |
| NCT03804463 | The Multicentic Trial in Fertility-sparing Treatment and Ovarian Preservation Management for Early Endometrial Cancer | unknown | N/A | 170 | Min WangOTHER | 1 | Jan 15, 2019 | clinicaltrials |
| NCT03778255 | Sentinel Lymph Node Mapping In Endometrial Cancer(SLNMIEC) | unknown | N/A | 635 | Peking University People's HospitalOTHER | 1 | Dec 19, 2018 | clinicaltrials |
| NCT03553589 | Biomarkers for Diagnosis and Prognosis of Endometrial Carcinoma(BioEndoCar) | unknown | — | 400 | Andrea RomanoOTHER | 3 | Dec 5, 2018 | clinicaltrials |
| NCT03744962 | MSI in Circulatory DNA of Endometrial Cancer | unknown | — | 100 | Lei LiOTHER | 1 | Nov 19, 2018 | clinicaltrials |
| NCT03291106 | Study of Universal Screening for Lynch Syndrome in Chinese Patients of Endometrial Cancer | unknown | — | 1,500 | Lei LiOTHER | 1 | Nov 14, 2018 | clinicaltrials |
| NCT02667431 | Cancer of the Uterus and Treatment of Stress Urinary Incontinence(CUTI) | unknown | — | 556 | Women and Infants Hospital of Rhode IslandOTHER | 1 | Oct 2, 2018 | clinicaltrials |
| NCT03469531 | Study of Nimotuzumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer | unknown | Phase 2 | 100 | Zhujiang HospitalOTHER | 1 | Aug 13, 2018 | clinicaltrials |
| NCT00916708 | Trial Between Two Follow up Regimens With Different Test Intensity in Endometrial Cancer Treated Patients(TOTEM) | unknown | N/A | 1,884 | Azienda Ospedaliera San Giovanni BattistaOTHER | 1 | Aug 2, 2018 | clinicaltrials |
| NCT03567655 | Fertility-sparing Management Using High-dose Oral Progestin in Young Women With Endometrial Cancer | unknown | Phase 2 | 41 | Asan Medical CenterOTHER | 1 | Jun 26, 2018 | clinicaltrials |
| NCT03538704 | Effect of Fertility-sparing Therapy of Early Endometrial Cancer(ECFerSp) | unknown | N/A | 80 | Peking University People's HospitalOTHER | 1 | May 29, 2018 | clinicaltrials |
| NCT03076372 | A Study Evaluating MM-310 in Patients With Solid Tumors | unknown | Phase 1 | 34 | Merrimack PharmaceuticalsINDUSTRY | 1 | Feb 27, 2018 | clinicaltrials |
| NCT03291275 | Survival Outcomes of Uterine Malignancies in Chinese Population | unknown | — | 10,000 | Lei LiOTHER | 1 | Feb 8, 2018 | clinicaltrials |
| NCT02178462 | Biomarkers for Gynecologic Cancer | unknown | — | 153 | Ajinomoto Co., Inc.INDUSTRY | 1 | Jan 31, 2018 | clinicaltrials |
| NCT01853865 | Follow-up of Endometrial Cancer Patients(OPAL) | unknown | N/A | 211 | Odense University HospitalOTHER | 1 | Nov 6, 2017 | clinicaltrials |
| NCT02684318 | Study to Evaluate PM01183 in Combination With Olaparib in Advanced Solid Tumors | unknown | Phase 1 / Phase 2 | 100 | Poveda, Andrés, M.D.INDIV | 1 | Jun 22, 2017 | clinicaltrials |
| NCT01461746 | Efficacy Study of Chemotherapy Followed by Radiation Therapy to Treat Endometrial Cancer | unknown | Phase 2 | 67 | Asan Medical CenterOTHER | 1 | May 31, 2017 | clinicaltrials |
| NCT01461759 | Efficacy Study of Chemotherapy to Treat Advanced or Recurrent Endometrial Cancer | unknown | Phase 2 | 59 | Asan Medical CenterOTHER | 1 | May 31, 2017 | clinicaltrials |
| NCT02064725 | Virexxa (Sodium Cridanimod) w/Progestin Therapy in Pts w/Progesterone Receptor Neg Recurrent/Persistent Endometrial CA | unknown | Phase 2 | 8 | Kevelt ASINDUSTRY | 5 | Jan 24, 2017 | clinicaltrials |
| NCT02990728 | Mirena® ± Metformin as Fertility-preserving Treatment for Young Asian Women With Early Endometrial Cancer | unknown | Phase 2 | 120 | Chang Gung Memorial HospitalOTHER | 0 | Dec 13, 2016 | clinicaltrials |
| NCT02560571 | Pre-operative Studies for Prediction of Lymph Nodes Involvement in Endometrial Cancer Patients | unknown | Phase 2 | 200 | Meir Medical CenterOTHER | 1 | Sep 20, 2016 | clinicaltrials |
Data updated 22 days agoSource updated Dec 21, 2020source: clinicaltrials